|
AEON Aeon Biopharma Inc 1837607 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-11,793,000.00 |
| Balance Sheet |
|
Current Assets
|
$6,625,000.00 |
|
Assets
|
$8,630,000.00 |
|
Current Liabilities
|
$6,669,000.00 |
|
Liabilities
|
$25,382,000.00 |
|
Equity
|
$-16,752,000.00 |
|
Shares Out
|
25303058.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,636,000.00 |
|
Investing Cash Flow
|
$-4,000.00 |
| Market Analysis |
Market Cap
|
$6,578,795.08 |
|
Price
|
$0.29 |
|
PB
|
0.96 |
|
EPS
|
-0.29 |
|
FCF
|
$-2,640,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AEON documents filed with the SEC.
AEON Filings
Clear
